EPA Office of Chemical Safety & Pollution Prevention (OCSPP) - - PowerPoint PPT Presentation

epa office of chemical safety pollution prevention ocspp
SMART_READER_LITE
LIVE PREVIEW

EPA Office of Chemical Safety & Pollution Prevention (OCSPP) - - PowerPoint PPT Presentation

EPA Office of Chemical Safety & Pollution Prevention (OCSPP) Vision and Priorities Under TOXIC SUBSTANCES CONTROL ACT (TSCA) & FEDERAL INSECTICIDE, FUNGICIDE, & RODENTICIDE ACT (FIFRA) Alexandra Dapolito Dunn Office of Chemical


slide-1
SLIDE 1

EPA Office of Chemical Safety & Pollution Prevention (OCSPP) Vision and Priorities Under

TOXIC SUBSTANCES CONTROL ACT (TSCA) & FEDERAL INSECTICIDE, FUNGICIDE, & RODENTICIDE ACT (FIFRA)

Alexandra Dapolito Dunn Office of Chemical Safety and Pollution Prevention U.S. Environmental Protection Agency March 4, 2019

slide-2
SLIDE 2

TSCA and FIFRA Priorities

  • Delivering results and meeting statutory

requirements

  • Maintaining transparency and engaging partners,

stakeholders, and the public

  • Relying on the best available science
  • Increasing public confidence in chemical and

pesticide safety

  • Ensuring environmental justice

2

slide-3
SLIDE 3

TSCA Milestones: 2016-2018

Lautenberg Act signed into law

June 22

2016 2017

Section 6 rules for TCE, MC, and NMP proposed Active-inactive inventory rule proposed

First Anniversary of Lautenberg

Published final risk evaluation process rule Published scopes for the first 10 chemicals Published final prioritization process rule Mercury inventory rule proposed

  • Dec. ‘16-Jan. ‘17

January 13 Final active-inactive inventory rule

June 22 June 22 October 26

Mercury inventory report published

March 29

Proposed risk evaluation process rule January 19 Proposed prioritization process rule January 17 Published list of first 10 chemicals for risk evaluation Scientific Advisory Committee on Chemicals chartered December 19

2018

Existing Chemicals Fee Program Alternatives Inventory Update Mercury Transparency/CBI Fees rule proposed Strategic plan to reduce vertebrate animal testing proposed

Second Anniversary of Lautenberg

Issued final strategy to reduce vertebrate animal testing

February 8 March 12

Expanded access to CBI guidance published TSCA unique identifier policy published CBI generic name guidance published

June 22 June 22

Systematic review approach published Problem formulations for the first 10 published

June 1

Pre-prioritization approach published Final mercury inventory rule

June 22 September 27

Final fees rule published

October 17

Public meeting on the strategic plan to reduce vertebrate animal testing proposed

November 2

Public meeting on risk evaluation scoping efforts for the first 10 February 14 Public meeting on approaches for identifying potential candidates for prioritization for risk evaluation Public meeting on the new chemicals review program December 19 December 11

slide-4
SLIDE 4

FIFRA ACCOMPLISHMENTS & PRIORITIES

slide-5
SLIDE 5

2018 Accomplishments Under FIFRA & PRIA

  • Completed 99.7% of registration actions on-time
  • Registered 23 new active ingredients and 147 new uses of existing

pesticides

  • Registration Review --As of end of FY18, OPP has completed:

ü 477 draft risk assessments ü 385 proposed interim decisions ü 326 final or interim decisions

  • Worked collaboratively with state and Federal partners
  • Critical in making 2018 decision to extend the “over the top” registrations of dicamba
  • Advanced alternatives to animal testing
  • In FY18 alone, OCSPP prevented use of 16,500 test animals and saved the

regulated community >$8.9 million in costs by waiving data requirements.

5

slide-6
SLIDE 6

FY19 FIFRA Priorities

  • Continue to meet PRIA statutory deadlines and

progress the registration review program

  • Complete proposed interim decisions for glyphosate,

atrazine, neonicotinoids, and pyrethroids

  • Engage and collaborate with Federal partners on key

science and policy issues including biotechnology

  • Implement relevant sections of the 2018 Farm Bill
  • Endangered Species Act (ESA) interagency working group &

biostimulants

6